Skip to main content
Log in

Anaerobic Glycolysis Protection against 1-Methy-4-Phenylpyridinium (MPP+) Toxicity in C6 Glioma Cells

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

The neurotoxin 1-methy-4-phenylpyridinium (MPP+) is used for its’ capacity to induce Parkinsonism through its inhibitory effects on mitochondrial complex I. This inhibition disrupts cellular energy formation and aerobic glycolysis. The objective of this study was to demonstrate that the toxic effect of mitochondrial aerobic pathway inhibition with MPP+ can be reduced by stimulating anaerobic glycolysis using glucose supplementation. In this study, C6 Glioma cell viability was examined in the presence of different concentrations of MPP alone and with the addition of glucose. The results obtained indicate that there was a significant increase (P < 0.001) in cell viability in cells treated with glucose and MPP+ verses cells treated with MPP+ alone. Fluorometric analysis using 100 uM Rhodamine 123 indicated mitochondrial membrane potential was not restored in MPP+ treated cells with glucose; however, normal cell viability was confirmed using 2 ug/ml Fluorescein diacetate. This dual fluorescence indicated mitochondrial damage from MPP+ while glucose augmented cell survival. Further confirmation of cell survival upon damage to the mitochondria was evident in TUNEL staining. Positive staining was prominent only in MPP+ treatment groups alone, while control and co-treated groups exhibited little to no TUNEL staining. ATP measurements of all MPP+ treated groups exhibited a significant (P < 0.001) decrease verses control. Groups co-treated with MPP+ and glucose revealed a significant increase (250 μM group: P < 0.001) in ATP. It was concluded from this study that glucose supplementation was able to sustain cellular viability and ATP production through anaerobic glycolysis despite the inhibitory effect of MPP+ on aerobic glycolysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Blum D, Torch S, Lambeng N, Nissou M-F, Benabid A-L, Sadoul R, Verna J-M (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine, and MPTP: contribution to the apoptotic theory in Parkinson’s disease. Prog Neurobiol 65:135–172

    Article  PubMed  CAS  Google Scholar 

  2. Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Life Sci 36:2503–2508

    Article  PubMed  CAS  Google Scholar 

  3. Ramsay RE, Singer RP (1986) Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine by mitochondria. J Biol Chem 75:85–7587

    Google Scholar 

  4. Di Monte D, Sandy MS, Ekstrom G, Smith MT (1986) Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridinium (MPP+) cytotoxicity. Biochem Biophys Res Commun 137:303–309

    Article  PubMed  CAS  Google Scholar 

  5. Denton T, Howard BD (1987) A dopaminergic cell line resistant to the neurotoxin. 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J Neurochem 49:622–630

    Article  PubMed  CAS  Google Scholar 

  6. Chan P, DeLanney LS, Irwin I, Langston JW, Di Monte D (1984) Rapid ATP loss caused by of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J Neurochem 57:348–351

    Article  Google Scholar 

  7. Scotcher KP, Irwin I, DeLanney LE, Langston JW, Di Monte D (1990) Effects of 1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse synaptosomes. J Neurochem 54:1295–1301

    Article  PubMed  CAS  Google Scholar 

  8. Dauer W, Przedborski S (2003) Parkinson’s disease: mechanisms and models. Neuron 39:889–909

    Article  PubMed  CAS  Google Scholar 

  9. Smith MT, Ekstrom G, Sandy MS, Di Monte D (1987) Studies on the mechanism of cytotoxicity in isolated hepatocytes. Life Sci 40:741–748

    Article  PubMed  CAS  Google Scholar 

  10. Mizuno Y, Saitoh T, Sone N (1987) Inhibition of mitochondrial NADH–ubiquinone oxidoreductase activity by 1-methylphenylpyridinium ion. Biochem Biophys Res Commun 143:294–299

    Article  PubMed  CAS  Google Scholar 

  11. Chan P, DeLanney LS, Irwin I, Langston JW, Di Monte D (1991) Rapid ATP loss caused by of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J Neurochem 57:348–351

    Article  PubMed  CAS  Google Scholar 

  12. Di Monte DA, Wu EY, Irwin I, Delanney LE, Langston JW (1991) Biotransformation of in primary cultures of mouse astrocytes. J Pharmacol Exp Ther 258:594–600

    PubMed  CAS  Google Scholar 

  13. Bates TE, Heales SJ, Davies SE, Boakye P, Clark JB (1994) Effects of 1-methyl-4-phenylpyridinium on isolated rat brain mitochondria: evidence for a primary involvement of energy depletion. J Neurochem 63:640–648

    Article  PubMed  CAS  Google Scholar 

  14. Forno LS, Delanny LE, Irwin I, Di Monte D, Langston JW (1992) Astrocytes and Parkinson’s disease. Prog Brain Res 94:429–436

    Article  PubMed  CAS  Google Scholar 

  15. Chiba K, Trevor A, Castagnoli N Jr (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain oxidase. Biochem Biophy Res Comm 120:574–578

    Article  CAS  Google Scholar 

  16. Langston JW, Irwin I, Langston EB, Forno LS (1984) 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci Lett 48:87–92

    Article  PubMed  CAS  Google Scholar 

  17. Ransom BR, Kunis DM, Irwin I, Langston JW (1987) Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+. Neurosci Lett 75:323–328

    Article  PubMed  CAS  Google Scholar 

  18. Brooks WJ, Jarvis MF, Wagner GC (1989) Astrocytes as primary locus for the conversion of MPTP in MPP+. J Neural Transm 76:1–12

    Article  PubMed  CAS  Google Scholar 

  19. Wu EY, Langston JW, Di Monte DA (1992) Toxicity of the 1-methyl-2, 3-dihydtopyridinium and 1-methyl-4-phenylpryidinium species in primary cultures of mouse astrocyte. J Pharmacol Exp Ther 62:2259–2230

    Google Scholar 

  20. Mazzio E, Soliman K (2003) The role of glycolysis and gluconeogenesis in the cytoprotection of neuroblastoma cells against 1-methyl-3-phenyl-pyridinium ion toxicity. Neurotoxicology 24:137–147

    Article  PubMed  CAS  Google Scholar 

  21. Di Monte DA, Wu EY, Delanney Irwin I, Langston JW (1992) Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes. J Pharmacol Exp Ther 261:144–149

    Google Scholar 

  22. Marcelo MN, Assaf S, Petros B, Carlo R (1998) A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J Immunological Methods 213:157–167

    Article  Google Scholar 

  23. Youngster SK, Sonsalla PK, Heikkila RE (1987) Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J Neurochem 48:989–934

    Article  Google Scholar 

  24. Basma AN, Heikkila RE, Nicklas WJ, Giovanni A, Geller HM (1990) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4- (2`-ethylphenyl)-1,2,3,6- tetrahydropyridine induced toxicity in PC12 cells: role of monoamine oxidase A. J Neurochem 55:870–877

    Article  PubMed  CAS  Google Scholar 

  25. Chamlmers-Redman RM, MacLean Fraser AD, Carlile GW, Pong A, Tatton WG (1999) Glucose protection from MPP-induced apoptosis depends on mitochondrial membrane potential and ATP synthase. Biochem Biophy Res Comm 257:440–447

    Article  Google Scholar 

  26. Hertz L, Yager JY, Juurlink BHJ (1995) Astrocyte survival in the absence of exogenous substrate: comparison of immature and mature cells. Int J Dev Neurosci 13:523–527

    Article  PubMed  CAS  Google Scholar 

  27. Hassouna I, Wickert H, Zimmermann M, Gillardon F (1996) Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) treatment of mice. Neurosci Lett 204:85–88

    Article  PubMed  CAS  Google Scholar 

  28. Tatton NA, Kish SJ (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labeling and Acridine Orange staining. Neuroscience 77:1037–1048

    Article  PubMed  CAS  Google Scholar 

  29. Eberhardt O, von Coelln R, Kügler S, Lindenau J, Rathke-Hartlieb S, Gerhardt E, Haid S, Isenmann S, Gravel C, Srinivasan A, Weller M, Bähr M, Dichgans J, Schulz JB (2000) Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. J Neurosci 20:9126–9134

    PubMed  CAS  Google Scholar 

  30. Turmel H, Hartmann A, Parain K, Douhou A, Srinivasan A, Agid Y, Hirsch EC Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Mov Disorders 16:185–189

  31. Viswanath V, Wu Y, Boonplueang R, Chen S, Stevenson FF, Yantiri F, Yang L, Beal MF, Andersen JK (2001) Caspase-9 activation results in downstream caspase activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s disease. J Neurosci 21:9519–9528

    PubMed  CAS  Google Scholar 

  32. Itano Y, Nomura Y (1995) 1-Methyl-4-phenylpyridinium ion (MPP+) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells through different mechanisms. Brain Res 704:240–245

    Article  PubMed  CAS  Google Scholar 

  33. Sheehan JP, Palmer PE, Helm GA, Tuttle JB (1997) MPP+ induced apoptotic cell death in SH-SY5Y neuroblastoma cells: an electron microscope study. J Neurosci Res 48:226–237

    Article  PubMed  CAS  Google Scholar 

  34. Dipasquale B, Marini AM, Youle RJ (1991) Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem Biophys Res Comm 181:1442–1448

    Article  PubMed  CAS  Google Scholar 

  35. Du Y, Dodel RC, Bales KR, Jemmersom R, Hamilton- Byrd E, Paul SM (1997) Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J Neurochem 69:1382–1388

    Article  PubMed  CAS  Google Scholar 

  36. Mochizuki H, Nakamura N, Nishi K, Mizuno Y (1994) Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-culture in rat. Neurosci Lett 170:191–194

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant received from the National Institutes of Health (RR 03020).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karam F. A. Soliman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, Z.R., Goodman, C.B. & Soliman, K.F.A. Anaerobic Glycolysis Protection against 1-Methy-4-Phenylpyridinium (MPP+) Toxicity in C6 Glioma Cells. Neurochem Res 32, 1071–1080 (2007). https://doi.org/10.1007/s11064-006-9276-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-006-9276-7

Keywords

Navigation